# DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study

> **NCT03961191** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 300 (estimated)

## Conditions studied

- DNA Methylation
- Uterine Cervical Cancer
- High Grade Squamous Intraepithelial Lesions
- Low Grade Squamous Intraepithelial Lesions

## Interventions

- **DIAGNOSTIC_TEST:** DNA methylation
- **DIAGNOSTIC_TEST:** high-risk HPV
- **DIAGNOSTIC_TEST:** TCT

## Key facts

- **NCT ID:** NCT03961191
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-22
- **Primary completion:** 2020-05-22
- **Final completion:** 2020-05-22
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961191, "DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03961191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*